Abstract | OBJECTIVE: METHODS: Choose 34 confirmed pneumoconiosis patients as drug treatment group and complex treatment group, and 17 tested workers as control group. Collected the content of TGF-beta1 and P III P which in these three investigated groups. RESULTS:
Drug treatment group and complex treatment group of patients improved the clinical symptoms and lung function Compared with Pretreatment, the FVC, FEV1.0, FEV1.0/FVC, MVV was obviously higher than those before treatment (P < 0.05). Complex treatment group than in the drug treatment group increased more significantly (P < 0.05). The level of TGF-beta1 and P III P was reduced after complex treatment (P < 0.05). Moreover,the level of TGF-beta1 and P III P in these patients are lower than in those patients treated with tetrandrine combined with whole lung lavage (P < 0.05). CONCLUSION:
|
Authors | Li-Jun Peng, Qi-Shang Zhu |
Journal | Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
(Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi)
Vol. 30
Issue 1
Pg. 68-70
(Jan 2012)
ISSN: 1001-9391 [Print] China |
PMID | 22730694
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Benzylisoquinolines
- Collagen Type III
- Transforming Growth Factor beta1
- tetrandrine
|
Topics |
- Adult
- Benzylisoquinolines
(therapeutic use)
- Bronchoalveolar Lavage
- Collagen Type III
(blood)
- Combined Modality Therapy
- Humans
- Male
- Middle Aged
- Pneumoconiosis
(blood, therapy)
- Transforming Growth Factor beta1
(blood)
- Treatment Outcome
|